S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
All the trading advice you’ve ever received boils down to this (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
All the trading advice you’ve ever received boils down to this (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
All the trading advice you’ve ever received boils down to this (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
All the trading advice you’ve ever received boils down to this (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa

Cleveland BioLabs Stock Price, News & Analysis (NASDAQ:CBLI)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.0003
▼
$0.0004
50-Day Range
$2.20
▼
$4.34
52-Week Range
$1.62
▼
$10.97
Volume
28,901 shs
Average Volume
271,922 shs
Market Capitalization
$6,191.60
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsHeadlinesSocial Media

CBLI stock logo

About Cleveland BioLabs Stock (NASDAQ:CBLI)

Cytocom, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule immunotherapies. Its product applies to autoimmune, inflammatory, infectious diseases and cancers. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Fort Collins, CO.


CBLI Stock News Headlines

September 2, 2023 | usatoday.com
Eagles' Tyrie Cleveland, Moro Ojomo carted off field after suffering neck injuries
July 28, 2023 | bizjournals.com
Cleveland Construction News
December 10, 2023 | Autonomix (Ad)
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
June 28, 2023 | health.usnews.com
Best Hospitals in Cleveland, OH
May 22, 2023 | abcnews.go.com
Cleveland EMS worker who went missing for 6 days remains hospitalized after found safe
May 17, 2023 | health.usnews.com
Cleveland Clinic Rehabilitation Hospital
April 19, 2023 | travel.usnews.com
Getting Around Cleveland
March 31, 2023 | thestreet.com
Cleveland BioLabs Stock Gaps Down On Today's Open (CBLI)
December 10, 2023 | Autonomix (Ad)
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
March 23, 2023 | bizjournals.com
Cleveland Manufacturing News
March 16, 2023 | bizjournals.com
Cleveland Commercial Real Estate News
March 12, 2023 | forbes.com
Cleveland, TN
September 9, 2022 | bizjournals.com
Cleveland News
August 31, 2022 | thestreet.com
5 Stocks Under $5 Making Big Moves
November 15, 2021 | finance.yahoo.com
Statera Biopharma Provides Third Quarter 2021 Financial and Corporate Update
October 26, 2021 | finance.yahoo.com
Cleveland BioLabs Gets Orphan Status for Entolimod in EU
September 24, 2021 | reuters.com
Statera Biopharma Inc
September 8, 2021 | finance.yahoo.com
What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
September 7, 2021 | finance.yahoo.com
Statera BioPharma: The Ticker Formerly Known as CBLI
September 2, 2021 | seekingalpha.com
Cytocom to rename as Statera BioPharma
August 31, 2021 | finance.yahoo.com
Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."
August 18, 2021 | seekingalpha.com
Cytocom, Inc. (CBLI) CEO Michael Handley on Q2 2021 Results - Earnings Call Transcript
August 16, 2021 | finance.yahoo.com
Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast
August 16, 2021 | finance.yahoo.com
Cytocom, Inc. Reports Second Quarter 2021 Financial Results
August 12, 2021 | finance.yahoo.com
Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement
August 11, 2021 | finance.yahoo.com
Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference
August 10, 2021 | finance.yahoo.com
Cytocom, Inc. to Report Second Quarter 2021 Financial Results
See More Headlines
Receive CBLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cleveland BioLabs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2020
Today
12/09/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CBLI
CUSIP
N/A
CIK
1318641
Web
www.cbiolabs.com
Phone
(888) 613-8802
Fax
N/A
Employees
4
Year Founded
2003

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-2,400,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-32.84%
Return on Assets
-31.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
45.93
Quick Ratio
45.93

Sales & Book Value

Annual Sales
$260,000.00
Price / Sales
0.02
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.87 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
15,479,000
Free Float
N/A
Market Cap
$6,191.60
Optionable
Not Optionable
Beta
0.70

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Michael Kevin Handley
    President, Chief Executive Officer & Director
  • Taunia S. Markvicka
    Chief Operating Officer & Director
  • Peter J. Aronstam
    Chief Financial Officer
  • Andrei V. Gudkov
    Global Head-Research & Development
  • Clifford A. Selsky
    Chief Medical Officer

Key Competitors

View All Competitors














CBLI Stock Analysis - Frequently Asked Questions

How were Cleveland BioLabs' earnings last quarter?

Cleveland BioLabs, Inc. (NASDAQ:CBLI) released its quarterly earnings data on Friday, May, 15th. The biotechnology company reported ($0.05) EPS for the quarter. The biotechnology company earned $0.16 million during the quarter.

What other stocks do shareholders of Cleveland BioLabs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cleveland BioLabs investors own include Inovio Pharmaceuticals (INO), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Tonix Pharmaceuticals (TNXP), Dynavax Technologies (DVAX), Gilead Sciences (GILD), Novavax (NVAX), Biocept (BIOC) and Co-Diagnostics (CODX).

This page (NASDAQ:CBLI) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -